(Total Views: 577)
Posted On: 03/11/2025 1:18:44 AM
Post# of 155807
Cancer excerpt from website:
Metastatic disease, not the primary tumor, is the cause of death in the vast majority of cancer patients.
From Cytodyn patent:
Currently, no treatments exist that are directed specifically to the metastatic process."
Dr. J: Oncology -- December 2024 Update:
The Company will be prioritizing oncology in 2025, as we believe this indication holds the potential for the highest value return to the Company in the form of a significant partnership and/or drug approval.
Metastatic disease, not the primary tumor, is the cause of death in the vast majority of cancer patients.
From Cytodyn patent:
Currently, no treatments exist that are directed specifically to the metastatic process."
Dr. J: Oncology -- December 2024 Update:
The Company will be prioritizing oncology in 2025, as we believe this indication holds the potential for the highest value return to the Company in the form of a significant partnership and/or drug approval.
(4)
(0)
